Concepedia

Brenda Melendez

BM

Statistics

Publications

10

Citations

755

H-Index

10

Active since

2012

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Brenda Melendez is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, immunology, and tumor immunity.

Top concepts

MedicineImmunologyTumor ImmunityImmunotherapyImmune EvasionImmuno-oncologyCell BiologyTumor BiologyTumor MicroenvironmentObesity

Publications per year

2012–2022

10

Publications

10

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Yared Hailemichael, Daniel H. Johnson, Noha Abdel‐Wahab et al. · Cancer Cell · 2022 · 314 citations · Full text

Immune Evasion, Tumor Immunology, Cancer Immunosurveillance +5

BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma

Sherille D. Bradley, Zeming Chen, Brenda Melendez et al. · Cancer Immunology Research · 2015 · 161 citations · Full text

Rapid Mhc-i Internalization, Cancer Immunosurveillance, Signal Transduction +15

Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy

Yasmin A. Lyons, Sunila Pradeep, Sherry Y. Wu et al. · Oncotarget · 2017 · 58 citations · Full text

Activation of the Inflammasome and Enhanced Migration of Microparticle-Stimulated Dendritic Cells to the Draining Lymph Node

Ismail M. Meraz, Brenda Melendez, Jianhua Gu et al. · Molecular Pharmaceutics · 2012 · 47 citations · Full text

SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity

Jungsun Park, Amjad H. Talukder, Seon Ah Lim et al. · Cancer Immunology Research · 2017 · 46 citations · Full text

1–5 of 10